Remodeled | Non-remodeled | All | |
---|---|---|---|
Age (y) | 54±12 | 53±10 | 55±10 |
Sex | |||
Male | 16 | 28 | 44 |
Female | 0 | 2 | 2 |
Body Surface Area (kg/m2) | 1.91±0.33 | 1.96±0.2 | 1.97±0.18 |
Systolic blood pressure (mmHg) | 131±32 | 128±28 | 133±28 |
Diastolic blood pressure (mmHg) | 83±22 | 85±22 | 84±20 |
Heart Rate (min-1) | 73±18 | 73±13 | 75±16 |
Diabetes mellitus (%) | 19% | 13% | 15% |
Current or ex-smoker (%) | 44% | 67% | 59% |
Hypertension (%) | 38% | 37% | 37% |
Time from symptoms to reperfusion (hours) | 3.5±2.6 | 3.4±3.0 | 3.5±2.6 |
Peak Creatinine kinase (IU/L) | 2216±1994 | 1775±1581 | 2240±2034 |
Peak Troponin I (μg/L) | 65.0±78.7 | 63.6±92.2 | 64±80 |
Culprit coronary artery (%) | |||
Left anterior descending | 56 | 53 | 54 |
Circumflex artery | 6 | 17 | 13 |
Right coronary | 38 | 30 | 33 |
TIMI flow Pre-PPCI (%) | |||
Grade 0 | 94 | 80 | 85 |
Grade I | 6 | 3 | 9 |
Grade II | 0 | 7 | 4 |
Grade III | 0 | 0 | 0 |
TIMI flow Post-PPCI (%) | |||
Grade II | 6 | 0 | 4 |
Grade III | 63 | 100 | 96 |
Discharge medication (%) | |||
Aspirin | 100 | 100 | 100 |
Clopidogrel | 96 | 96 | 96 |
Beta blocker | 94 | 90 | 92 |
Ca2+ channel blocker | 6 | 0 | 2 |
Angiotensin converting enzyme inhibitor | 98 | 94 | 96 |
Statin | 98 | 98 | 98 |